Local control of rhino‐orbito‐cerebral mucormycosis dramatically impacts survival. (6th November 2013)

• Record Type: Journal Article
• Authors: Vironneau, P.; Kania, R.; Morizot, G.; Elie, C.; Garcia‐Hermoso, D.; Herman, P.; Lortholary, O.; Lanternier, F.; the French Mycosis Study Group; Bottieau, E.
• Is Part Of: Clinical microbiology and infection. Volume 20:Number 5(2014:May)
• Page Start: O336
• Page End: O339
• Publication Date: 2013-11-06
• Subjects: Medical microbiology -- Periodicals; Diagnostic microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.01
• DOI: 10.1111/1469-0691.12408
• Languages: English
• ISSNs: 1198-743X

Abstract

<abstract abstract-type="main" id="clm12408-abs-0001"> <title>Abstract</title> <p>Surgery and antifungals are the reference standard for rhino‐orbito‐cerebral mucormycosis (ROCM) treatment. The impact of local control on survival of 22 consecutive ROCM adults was studied on day 90: none vs. 75% died, respectively, with or without local control (p &lt;0.0001). Hence, repeated surgical procedures are recommended to achieve local control of ROCM.</p> </abstract>